Peter Spanogiannopoulos, PhD

TitlePostdoctoral Scholar
InstitutionUniversity of California San Francisco
DepartmentHooper Foundation
Address513 Parnassus Ave
San Francisco CA 94143
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bisanz JE, Spanogiannopoulos P, Pieper LM, Bustion AE, Turnbaugh PJ. How to determine the role of the microbiome in drug disposition. Drug Metab Dispos. 2018 Aug 15. PMID: 30111623.
      View in: PubMed
    2. Spanogiannopoulos P, Turnbaugh PJ. Broad collateral damage of drugs against the gut microbiome. Nat Rev Gastroenterol Hepatol. 2018 May 11. PMID: 29752457.
      View in: PubMed
    3. Stogios PJ, Cox G, Spanogiannopoulos P, Pillon MC, Waglechner N, Skarina T, Koteva K, Guarné A, Savchenko A, Wright GD. Rifampin phosphotransferase is an unusual antibiotic resistance kinase. Nat Commun. 2016 Apr 22; 7:11343. PMID: 27103605; PMCID: PMC4844700.
    4. Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol. 2016 Apr; 14(5):273-87. PMID: 26972811.
      View in: PubMed
    5. Spanogiannopoulos P, Waglechner N, Koteva K, Wright GD. A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteria. Proc Natl Acad Sci U S A. 2014 May 13; 111(19):7102-7. PMID: 24778229; PMCID: PMC4024899.
    6. Thaker MN, Wang W, Spanogiannopoulos P, Waglechner N, King AM, Medina R, Wright GD. Identifying producers of antibacterial compounds by screening for antibiotic resistance. Nat Biotechnol. 2013 Oct; 31(10):922-7. PMID: 24056948.
      View in: PubMed
    7. Stogios PJ, Spanogiannopoulos P, Evdokimova E, Egorova O, Shakya T, Todorovic N, Capretta A, Wright GD, Savchenko A. Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistance. Biochem J. 2013 Sep 01; 454(2):191-200. PMID: 23758273; PMCID: PMC3743924.
    8. McArthur AG, Waglechner N, Nizam F, Yan A, Azad MA, Baylay AJ, Bhullar K, Canova MJ, De Pascale G, Ejim L, Kalan L, King AM, Koteva K, Morar M, Mulvey MR, O'Brien JS, Pawlowski AC, Piddock LJ, Spanogiannopoulos P, Sutherland AD, Tang I, Taylor PL, Thaker M, Wang W, Yan M, Yu T, Wright GD. The comprehensive antibiotic resistance database. Antimicrob Agents Chemother. 2013 Jul; 57(7):3348-57. PMID: 23650175; PMCID: PMC3697360.
    9. Spanogiannopoulos P, Thaker M, Koteva K, Waglechner N, Wright GD. Characterization of a rifampin-inactivating glycosyltransferase from a screen of environmental actinomycetes. Antimicrob Agents Chemother. 2012 Oct; 56(10):5061-9. PMID: 22802246; PMCID: PMC3457401.
    10. Thaker M, Spanogiannopoulos P, Wright GD. The tetracycline resistome. Cell Mol Life Sci. 2010 Feb; 67(3):419-31. PMID: 19862477.
      View in: PubMed
    Peter's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.